PHK
VIR icon

Point72 Hong Kong’s Vir Biotechnology VIR Stock Holding History

Point72 Hong Kong’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-19,572
Closed -$174K – 659
2024
Q2 		$174K Buy
19,572
+12,598
+181% +$121K 0.01% 303
2024
Q1 		$70.7K Sell
6,974
-6,579
-49% -$67K ﹤0.01% 440
2023
Q4 		$136K Buy
+13,553
New +$124K 0.01% 460
2022
Q4 		– Sell
-19,642
Closed -$379K – 1632
2022
Q3 		$379K Buy
+19,642
New +$499K 0.01% 840
2022
Q2 		– Sell
-6,835
Closed -$176K – 2443
2022
Q1 		$176K Buy
+6,835
New +$203K 0.01% 1008
2021
Q3 		– Sell
-7,565
Closed -$358K – 2465
2021
Q2 		$358K Buy
+7,565
New +$344K 0.01% 1001

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return